Streptase

Clinical Pharmacology

font size

Clinical Pharmacology

Streptase

There is a time-related decrease in effectiveness when Streptase, Streptokinase, is used in the management of peripheral arterial thromboembolism. When administered three to ten days after onset of obstruction, rates of clearance of 50-75% were reported.

Brand Name: Streptase
Generic Name: Streptokinase

« Previous
Clinical Pharmacology
Next »

Next: Streptase - Patient Information »
« Previous: Streptase - Overdosage & Contraindications

Bookmark this page:

Heart Health

Get the latest treatment options.

WebMD Resources

At Risk for Heart Disease?
Thanks to new technology, in just 15 seconds you can tell if you’re at risk for heart disease. Learn about this new tool. See more WebMD Videos »